Clin. Pharmacol. Ther.

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.

Cooper-DeHoff RM, Niemi M, Ramsey LB, ..., Caudle KE, Voora D

Clin. Pharmacol. Ther. 111 (5) 1007-1021 [2022-05-00; online 2022-03-11]

PharmVar GeneFocus: CYP2C9.

Sangkuhl K, Claudio-Campos K, Cavallari LH, ..., Daly AK, Gaedigk A

Clin. Pharmacol. Ther. 110 (3) 662-676 [2021-09-00; online 2021-07-12]

Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.

Nicoletti P, Devarbhavi H, Goel A, ..., Daly AK, Aithal GP

Clin. Pharmacol. Ther. 109 (4) 1125-1135 [2021-04-00; online 2020-12-05]

Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight.

Wegler C, Prieto Garcia L, Klinting S, ..., Andersson TB, Artursson P

Clin. Pharmacol. Ther. 109 (3) 762-771 [2021-03-00; online 2020-10-18]

Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.

Nicoletti P, Aithal GP, Chamberlain TC, ..., Daly AK, International Drug-Induced Liver Injury Consortium (iDILIC)

Clin. Pharmacol. Ther. 106 (1) 245-253 [2019-07-00; online 2019-03-19]

Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Wadelius M, Eriksson N, Kreutz R, ..., Hallberg P, EuDAC

Clin. Pharmacol. Ther. 103 (5) 843-853 [2018-05-00; online 2017-09-28]

Affiliated researcher

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.

Johnson JA, Caudle KE, Gong L, ..., Cavallari LH, Wadelius M

Clin. Pharmacol. Ther. 102 (3) 397-404 [2017-09-00; online 2017-04-04]

Affiliated researcher

Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

Wadelius M, Marshall SE, Islander G, ..., Hallberg P, Palmer CN

Clin. Pharmacol. Ther. 96 (4) 477-481 [2014-10-00; online 2014-06-24]

Phenotype standardization for statin-induced myotoxicity.

Alfirevic A, Neely D, Armitage J, ..., Palmer CN, Pirmohamed M

Clin. Pharmacol. Ther. 96 (4) 470-476 [2014-10-00; online 2014-06-04]

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Ramsey LB, Johnson SG, Caudle KE, ..., Wadelius M, Niemi M

Clin. Pharmacol. Ther. 96 (4) 423-428 [2014-10-00; online 2014-06-11]

Computational prospecting for drug-transporter interactions.

Matsson P, Artursson P

Clin. Pharmacol. Ther. 94 (1) 30-32 [2013-07-00; online 2013-04-02]